News | November 10, 2021
US govt places additional order of 1.4 million courses of molnupiravir
Molnupiravir is an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in at risk adults
Molnupiravir is an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in at risk adults
It was recognized for its holistic initiatives designed to improve the quality of life and standards of care for patients
The new facility will provide an important boost to vaccine capacity in Africa
Trivector Biomed has been promoting its Novaerus air disinfection solution across hospitals and health care facilities across India.
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
Venus Remedies has reported consolidated financial results for the period ended September 30, 2021
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
The Thermo Scientific Orbitrap Exploris MX enables customer success by combining high-quality data with operational simplicity
Dr. Reddy's Laboratories has reported consolidated financial results for the period ended September 30, 2021
It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years
Subscribe To Our Newsletter & Stay Updated
